In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

"The medication's going to be 50 percent of your journey, and the other 50 percent is still what you choose to eat and the ...

Some less expensive versions of popular weight loss drugs are no longer available to patients, after the Food & Drug ...

Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Semaglutide manufacturers seem to be taking advantage of America’s health crises to indulge in anticompetitive behavior.

As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...

A new bill could make the price of prescription drugs known for weight loss cheaper for the state of Ohio to buy for its ...